UTAH MEDICAL PRODUCTS INC

UTMD

UTAH MEDICAL PRODUCTS INC

UTMD

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2023-05-18Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:2,205,262Shares Outstanding:3,185,000Institutional Ownership Pct.:69.24%

Earnings Market Reaction:

Filing Date:2026-08-12Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	88	87	86	84	82	83	83	88	89	94	93	88
Accounts Receivable Net Current	4	4	4	4	4	4	4	4	4	4	3	3
Inventory Net	9	9	8	8	8	9	9	9	9	9	10	10
Other Assets Current	1	1	1	0	0	0	0	0	0	1	0	0
Assets Current	101	100	98	97	94	96	96	102	102	107	106	102
Property Plant And Equipment Net	10	10	10	10	10	10	10	10	10	10	11	10
Goodwill	14	14	14	14	14	14	14	14	14	14	14	13
Finite Lived Intangible Assets Gross	55	55	56	56	57	55	54	56	54	54	54	53
Finite Lived Intangible Assets Accumulated Amortiz…	-55	-55	-55	-55	-55	-52	-51	-52	-50	-50	-49	-47
Intangible Assets Net Excluding Goodwill	0	0	1	1	2	2	3	4	4	4	5	6
Assets	125	124	123	122	121	123	123	130	130	135	135	131
Liabilities Current
Liabilities And Stockhold…
Accounts Payable Current	1	1	1	1	1	1	1	1	1	1	1	1
Tax Cuts And Jobs Act Of2017 Transition Tax For Ac…	-	-	-	-	-	-	-	-	-	-	1	-
Other Liabilities Noncurrent	-	-	-	-	-	-	0	1	1	1	1	1
Operating Lease Liability Noncurrent	-	-	-	-	-	-	-	0	0	0	0	0
Accrued Liabilities Current	1	2	2	2	2	3	3	2	3	4	4	4
Liabilities Current	2	4	3	3	2	4	4	3	4	5	5	4
Deferred Tax Liabilities Goodwill And Intangible A…	0	0	0	0	0	0	1	1	1	1	1	1
Other Long Term Debt Noncurrent	-	-	-	0	0	0	-	-	-	-	-	-
Operating Lease Liability	-	-	-	-	0	-	-	-	-	-	-	-
Long Term Debt And Capital Lease Obligations	0	0	0	-	-	0	0	-	-	-	0	-
Deferred Income Tax Liabilities Net	0	0	0	0	0	0	0	0	0	0	0	1
Liabilities	3	4	3	4	3	5	5	5	6	8	7	8
Commitments And Contingencies	-	-	0	-	-	-	0	-	-	-	0	-
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Accumulated Other Comprehensive Income Loss Before…	-10	-10	-9	-10	-9	-11	-12	-10	-11	-11	-11	-12
Additional Paid In Capital Common Stock	0	0	0	0	0	0	0	0	0	0	1	1
Retained Earnings Accumulated Deficit	132	130	129	128	127	128	129	134	135	139	138	135
Stockholders Equity	122	120	119	118	118	117	117	124	124	128	128	124
Liabilities And Stockholders Equity	125	124	123	122	121	123	123	130	130	135	135	131
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	50	50	50	50	50	50	50	50	50	50	50	50
Common Stock Shares Issued	3	3	3	3	3	3	3	3	3	4	4	4
Shares Outstanding	3	3	3	3	3	3	3	3	3	4	4	4

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	6.00%	14.57%	9.51%	-	-	-	-	-	-	-	-	-
2025	2.39%	7.14%	0.74%	10.11%	10.47%	1.40%	1.14%	2.58%	10.85%	14.80%	2.92%	10.24%
2024	-0.65%	-2.37%	1.53%	2.03%	0.59%	-3.36%	-6.60%	-9.80%	-9.98%	-7.79%	-2.86%	-2.75%
2023	-	-	-	-	-	-	-1.13%	-0.34%	-5.13%	0.65%	2.32%	-1.56%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	48.62	28.64	37.62	32.06	41.87	22.29	25.64	29.59	25.98	19.57	22.56	24.38
Quick Ratio	44.27	26.15	34.57	29.36	38.22	20.29	23.29	26.94	23.68	17.89	20.53	22.06
Working Capital	98.57M	96.87M	95.14M	93.52M	92.12M	92.08M	92.57M	98.22M	98.38M	101.68M	101.56M	97.67M
Leverage & Debt
Debt to Equity	0.02	0.03	0.03	0.03	0.03	0.05	0.04	0.04	0.05	0.06	0.06	0.06
Debt Ratio	0.02	0.03	0.03	0.03	0.03	0.04	0.04	0.04	0.05	0.06	0.05	0.06
Efficiency & Turnover
Asset Turnover TTM	0.29	0.30	0.31	0.31	0.31	0.30	0.32	0.34	0.36	0.37	0.39	0.41
Days Sales Outstanding TTM	36.38	36.86	36.08	35.17	34.31	35.01	33.40	29.84	28.49	27.57	32.45	33.76
Receivables Turnover TTM	10.03	9.90	10.12	10.38	10.64	10.42	10.93	12.23	12.81	13.24	11.25	10.81
Per Share Metrics
Diluted EPS TTM	3.29	3.41	-	3.62	3.87	3.92	-	4.39	4.43	4.53	-	4.65
Free Cash Flow Per Share TTM	3.60	4.09	4.49	4.33	4.25	4.12	4.38	4.86	5.12	5.53	5.96	6.07
Dividend Per Share TTM	1.24	1.24	1.25	1.26	1.27	1.27	1.28	1.23	1.22	1.19	1.18	1.17
Margin Metrics
Gross Profit Margin TTM	57.90%	57.94%	57.12%	57.10%	57.32%	58.35%	59.03%	58.80%	58.99%	59.05%	59.81%	60.75%
Operating Profit Margin TTM	28.43%	28.81%	29.60%	30.78%	32.51%	32.76%	33.23%	33.14%	32.71%	33.07%	33.40%	34.79%
Net Profit Margin TTM	29.04%	28.91%	29.30%	30.08%	32.33%	33.00%	33.92%	34.62%	33.56%	33.39%	33.12%	32.85%
Growth Metrics
Net Revenue Growth (1Y)	-7.00%	-4.43%	-5.83%	-12.35%	-16.64%	-19.92%	-18.56%	-14.36%	-10.28%	-6.54%	-3.93%	-0.30%
Net Income Growth (1Y)	-16.46%	-16.28%	-18.65%	-23.83%	-19.68%	-20.87%	-16.60%	-9.74%	-9.39%	-4.52%	0.98%	5.33%
EPS Growth (1Y)	-14.84%	-13.00%	-14.85%	-17.39%	-12.60%	-13.51%	-9.22%	-5.82%	-6.93%	-4.26%	0.93%	5.22%
Valuation Metrics
P/E TTM	20.94	18.12	15.65	17.12	14.43	13.96	14.33	14.72	14.51	15.03	17.50	17.52
P/B TTM	1.80	1.63	1.48	1.68	1.54	1.55	1.69	1.81	1.83	1.93	2.27	2.39
P/S TTM	6.08	5.24	4.58	5.15	4.67	4.61	4.86	5.10	4.87	5.02	5.80	5.76
Market Cap	219.63M	196.53M	176.61M	198.96M	181.15M	180.86M	198.81M	224.59M	226.73M	246.10M	291.19M	296.22M
Enterprise Value	132.30M	109.34M	91.08M	114.70M	98.97M	97.80M	116.12M	136.14M	137.52M	152.29M	198.62M	208.01M
Calculated Values
Free Cash Flow TTM	11.45M	13.02M	14.32M	13.88M	13.80M	13.63M	14.60M	16.92M	18.08M	20.02M	21.64M	22.04M
Net Debt	-87.33M	-87.20M	-85.53M	-84.27M	-82.18M	-83.06M	-82.69M	-88.45M	-89.22M	-93.81M	-92.57M	-88.21M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2023-05-18Sale

Owner: Richins, Paul O

Title: -

Shares: 700

Price/Share: $93.47

Value: $65,429.00

Shares Owned: 21,461

Relationship: Director

Ownership: Indirect

2022-11-18Sale

Owner: Richins, Paul O

Title: -

Shares: 449

Price/Share: $90.81

Value: $40,773.69

Shares Owned: 22,311

Relationship: Director

Ownership: Indirect

2022-11-17Sale

Owner: Richins, Paul O

Title: -

Shares: 161

Price/Share: $90.00

Value: $14,490.00

Shares Owned: 22,760

Relationship: Director

Ownership: Indirect

2022-11-11Sale

Owner: Richins, Paul O

Title: -

Shares: 40

Price/Share: $92.50

Value: $3,700.00

Shares Owned: 22,921

Relationship: Director

Ownership: Indirect

2022-05-11Sale

Owner: Payne, Barbara A

Title: -

Shares: 2,000

Price/Share: $85.20

Value: $170,400.00

Shares Owned: 5,338

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2023-05-18	Richins, Paul O	Director	-	Indirect	Sale	700	93.47	$65,429.00	21,461	4
2022-11-18	Richins, Paul O	Director	-	Indirect	Sale	449	90.81	$40,773.69	22,311	4
2022-11-17	Richins, Paul O	Director	-	Indirect	Sale	161	90.00	$14,490.00	22,760	4
2022-11-11	Richins, Paul O	Director	-	Indirect	Sale	40	92.50	$3,700.00	22,921	4
2022-05-11	Payne, Barbara A	Director	-	Direct	Sale	2,000	85.20	$170,400.00	5,338	4
2021-11-24	Hoyer, Ernst G	Director	-	Indirect	Sale	4,900	126.41	$619,409.00	5,000	4
2021-11-18	Payne, Barbara A	Director	-	Direct	Sale	1,249	111.06	$138,713.94	7,838	4
2021-08-30	Payne, Barbara A	Director	-	Direct	Sale	1,000	88.48	$88,480.00	9,838	4
2021-08-25	Payne, Barbara A	Director	-	Direct	Sale	1	88.00	$88.00	11,837	4
2021-03-10	Payne, Barbara A	Director	-	Direct	Sale	1,000	90.00	$90,000.00	11,838	4
2020-06-05	Cornwell, Kevin L	Director,Officer	Chairman, CEO, Secretary	Indirect	Sale	1,000	107.56	$107,560.00	190,472	4
2020-06-05	Payne, Barbara A	Director	-	Direct	Sale	1,000	108.00	$108,000.00	13,338	4
2020-06-04	Cornwell, Kevin L	Director,Officer	Chairman, CEO, Secretary	Indirect	Sale	1,385	106.10	$146,948.50	191,472	4
2020-06-02	Payne, Barbara A	Director	-	Direct	Sale	1,000	102.04	$102,040.00	14,338	4
2020-05-27	Payne, Barbara A	Director	-	Direct	Sale	1,000	95.00	$95,000.00	15,338	4
2020-05-27	Richins, Paul O	Director	-	Indirect	Sale	650	95.71	$62,211.50	23,374	4
2020-05-26	Payne, Barbara A	Director	-	Direct	Sale	770	92.00	$70,840.00	16,338	4
2020-05-21	Payne, Barbara A	Director	-	Direct	Sale	230	92.37	$21,245.10	17,108	4
2020-05-18	Payne, Barbara A	Director	-	Direct	Sale	1,000	87.00	$87,000.00	17,338	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

69.24%

Inst. Shares: 2,205,262

Shares Outstanding: 3,185,000

2025-12-31

64.99%

Inst. Shares: 2,070,084

Shares Outstanding: 3,185,000

2025-09-30

66.52%

Inst. Shares: 2,133,174

Shares Outstanding: 3,207,000

2025-06-30

65.24%

Inst. Shares: 2,117,600

Shares Outstanding: 3,246,000

2025-03-31

66.24%

Inst. Shares: 2,192,569

Shares Outstanding: 3,310,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	2,205,262	3,185,000	69.24%
2025-12-31	2,070,084	3,185,000	64.99%
2025-09-30	2,133,174	3,207,000	66.52%
2025-06-30	2,117,600	3,246,000	65.24%
2025-03-31	2,192,569	3,310,000	66.24%
2024-12-31	2,257,493	3,310,000	68.20%
2024-09-30	2,353,015	3,478,000	67.65%
2024-06-30	2,322,970	3,532,000	65.77%
2024-03-31	2,184,143	3,618,000	60.37%
2023-12-31	1,940,241	3,618,000	53.63%
2023-09-30	1,923,266	3,629,000	53.00%
2023-06-30	1,894,259	3,628,000	52.21%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

UTAH MEDICAL PRODUCTS INC (UTMD) — SEC Financial Statements & Analysis

UTAH MEDICAL PRODUCTS INC (UTMD) is a surgical & medical instruments & apparatus company, incorporated in UT. UTAH MEDICAL PRODUCTS INC trades on Nasdaq as: UTMD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), UTAH MEDICAL PRODUCTS INC reported a -7.00% year-over-year revenue growth, a Gross Profit Margin of 57.90% (TTM), a Debt-to-Equity ratio of 0.02x, a Price-to-Sales (P/S) ratio of 6.08x (TTM), a Price-to-Book (P/B) ratio of 1.80x (TTM), at a market cap of $219.63M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -7.00%
Gross Profit Margin TTM: 57.90%
Debt To Equity: 0.02x
P/S TTM: 6.08x
P/B TTM: 1.80x
Market Cap: $219.63M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is UTAH MEDICAL PRODUCTS INC in?

UTAH MEDICAL PRODUCTS INC (UTMD) operates in the Surgical & Medical Instruments & Apparatus industry.

What is UTMD's market cap?

UTAH MEDICAL PRODUCTS INC (UTMD) has a market capitalization of $219.63M as of 2026-06-30.

What is UTMD's P/E ratio?

UTAH MEDICAL PRODUCTS INC (UTMD)'s trailing twelve month P/E ratio is 20.94x as of 2026-06-30.

What exchange does UTMD trade on?

UTAH MEDICAL PRODUCTS INC (UTMD) trades on the Nasdaq.

Where is UTAH MEDICAL PRODUCTS INC incorporated?

UTAH MEDICAL PRODUCTS INC is incorporated in UT.